| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Neurocrine Biosciences, Inc. (NBIX) has 17 insiders with recent SEC Form 4 filings, including 0 buys and 14 sells. NBIX is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 140.4K | $22.81M | - | |
| Other | 52.8K | $8.57M | - | |
| Other | 46.8K | $7.60M | - | |
| Other | 39.6K | $6.44M | -36,937 | |
| Other | 36.8K | $5.99M | -22,000 |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 31, 2023 | Boyer David W.51 | Chief Corp. Affairs Officer | Sell | 1,104 | $109.92 | $121,348.59 | -22.0% | -6.2% | +26.0% | |
| Jan 31, 2023 | Benevich Eric62 | Chief Commercial Officer | Sell | 1,207 | $109.95 | $132,710.25 | -6.7% | -6.2% | +26.0% | |
| Jan 31, 2023 | Abernethy Matt57 | Chief Financial Officer | Sell | 1,283 | $109.98 | $141,107.80 | -5.7% | -6.2% | +26.0% | |
| Jan 6, 2023 | Benevich Eric62 | Chief Commercial Officer | Sale+OE | 400 | $125.00 | $50,000.00 | -2.5% | -14.8% | +7.7% | |
| Jan 3, 2023 | Pops Richard F57 | Director | Sale+OE | 15,000 | $119.20 | $1,788,045.00 | -33.7% | -16.0% | +10.5% | |
| Jan 3, 2023 | Sherwin Stephen A | Director | Sale+OE | 30,000 | $118.86 | $3,565,728.00 | -37.4% | -16.0% | +10.5% | |
| Nov 30, 2022 | Benevich Eric62 | Chief Commercial Officer | Sale+OE | 50,000 | $125.90 | $6,295,085.00 | -51.6% | -18.9% | -8.2% | |
| Nov 29, 2022 | Onyia Jude54 | Chief Scientific Officer | Sell | 2,331 | $121.90 | $284,160.09 | -49.6% | -16.1% | -6.7% | |
| Nov 10, 2022 | Benevich Eric62 | Chief Commercial Officer | Sale+OE | 24,693 | $125.33 | $3,094,855.59 | -44.1% | -15.2% | -13.0% | |
| Nov 8, 2022 | Lippoldt Darin60 | Chief Legal Officer | Sale+OE | 5,082 | $125.04 | $635,441.59 | -14.8% | -15.2% | -6.9% |